drugset / Trial / NCT06115005
Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors
NaSingle-groupQuadruple-blindTreatment
Summary
Aim of the Study:To report the structural and visual outcomes of plasma rich in growth factors in closure of challenging macular holes
Timeline
- Start
- 2022-06-01
- Primary completion
- 2023-12-31
- Completion
- 2024-08-01
Publications
- Background Mahmoud TH, Thompson JT. The Treatment of Difficult Macular Holes. Ophthalmol Retina. 2021 Apr;5(4):315-316. doi: 10.1016/j.oret.2021.02.002. No abstract available.
- Background Arias JD, Hoyos AT, Alcantara B, Sanchez-Avila RM, Arango FJ, Galvis V. PLASMA RICH IN GROWTH FACTORS FOR PERSISTENT MACULAR HOLE: A PILOT STUDY. Retin Cases Brief Rep. 2022 Mar 1;16(2):155-160. doi: 10.1097/ICB.0000000000000957.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plasma rich in growth factors | Other / unclassified | — | — |